Delivery Order SPE2DB20D1109-SPE2DB24FP56X
Award Date
7/24/24
Potential Completion Date
8/14/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,605.44 firm-fixed-price contract is for the supply of 250 mg vials of the drug Ryanodex, with a completion date of July 2, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract has a ceiling value of $4,468.92 and a period of performance through September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by defense and civilian agencies to provide a wide range of essential...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,605.44, is for the delivery of 4,567,850,322 units of the medication RYANODEX 250 MG VIALS. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Ryanodex 250 mg vials. The contract has a ceiling value of $7,448.20 and a completion date of November 5, 2024. This order is not associated with any set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical products and...
This federal contract award, valued at $3,210.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product. The contract has a completion date of March 26, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4567771250 RYANODEX 250 MG VIALS. The contract has a ceiling value of $3,210.88 and a period of performance through April 8, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a ceiling value of $24,081.60 and a performance period ending on July 21, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $3,210.88 and a performance period through July 9, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.88, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...